Researchers at the Icahn School of Medicine at Mount Sinai (NY, USA) have developed a computational model that can predict ...

Any company looking to work with a CDMO should begin by defining its own product’s development requirements. For example, a ...

The tried and trusted animal model for drug development may not yet be in any danger of being phased out, but the alternatives that are emerging are providing a vision of a more efficient manner ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and ...

The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...

It usually takes more than a decade for a drug company to recoup the amount of money they put into the development of new ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

Traditional methods for identifying therapeutic gene targets, crucial for personalized medicine, are expensive and ...